Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Drug Cards Daily

#27: dicyclomine (Bentyl) | Treating Abdominal Pain Associated with IBS

19 Apr 2021

Description

Dicyclomine is an antispasmodic anticholinergic agent that is used to treat stomach and intestinal cramping that is often associated with irritable bowel syndrome (IBS). The brand name is Bentyl. There are various dosage forms such as oral and intramuscular solutions but the most commonly used are capsules. The capsules come in a 10 and 20 mg strength. When dosing to treat the abdominal pain associated with IBS, initiate 20 mg po qid for 2 weeks or less. Longer durations of treatment have not proven any additional benefits to the patient. Dicylomine works by blocking acetylcholine at parasympathetic sites such as the smooth muscle and secretory glands in the central nervous system. This drug is not recommended for children under 6 months old and in the geriatric population due to the risk of serious side effects. The two most common side effects are dizziness and xerostomia (dry mouth). If using antacids, separate usage between the two by using dicyclomine before meals and the antacid after meals.  Go to DrugCardsDaily.com for my episode show notes which will contain a drug summary, quiz, and a link to FREE drug card sheets. SUBSCRIBE on Spotify or Apple Podcasts or search for us on your favorite place to listen to podcasts. I will go over the Top 100-200 Drugs as well as throwing in some recently released drugs that peak my interest. Also, if you’d like to say hello, suggest a drug, or leave any constructive feedback on the show I’d really appreciate it! Leave a voice message at anchor.fm/drugcardsdaily or message us through twitter @drugcardsdaily

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.